BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12663508)

  • 1. Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2.
    Gago-Dominguez M; Bell DA; Watson MA; Yuan JM; Castelao JE; Hein DW; Chan KK; Coetzee GA; Ross RK; Yu MC
    Carcinogenesis; 2003 Mar; 24(3):483-9. PubMed ID: 12663508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotenoids/vitamin C and smoking-related bladder cancer.
    Castelao JE; Yuan JM; Gago-Dominguez M; Skipper PL; Tannenbaum SR; Chan KK; Watson MA; Bell DA; Coetzee GA; Ross RK; Yu MC
    Int J Cancer; 2004 Jun; 110(3):417-23. PubMed ID: 15095308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hair dye use and risk of bladder cancer in the New England bladder cancer study.
    Koutros S; Silverman DT; Baris D; Zahm SH; Morton LM; Colt JS; Hein DW; Moore LE; Johnson A; Schwenn M; Cherala S; Schned A; Doll MA; Rothman N; Karagas MR
    Int J Cancer; 2011 Dec; 129(12):2894-904. PubMed ID: 21678399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.
    Morton LM; Bernstein L; Wang SS; Hein DW; Rothman N; Colt JS; Davis S; Cerhan JR; Severson RK; Welch R; Hartge P; Zahm SH
    Carcinogenesis; 2007 Aug; 28(8):1759-64. PubMed ID: 17522066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary acetylated metabolites and N-acetyltransferase-2 genotype in human subjects treated with a para-phenylenediamine-containing oxidative hair dye.
    Nohynek GJ; Skare JA; Meuling WJ; Hein DW; De Bie AT; Toutain H
    Food Chem Toxicol; 2004 Nov; 42(11):1885-91. PubMed ID: 15350687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer.
    Yuan JM; Chan KK; Coetzee GA; Castelao JE; Watson MA; Bell DA; Wang R; Yu MC
    Carcinogenesis; 2008 Jul; 29(7):1386-93. PubMed ID: 18544563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects.
    Vaziri SA; Hughes NC; Sampson H; Darlington G; Jewett MA; Grant DM
    Pharmacogenetics; 2001 Feb; 11(1):7-20. PubMed ID: 11207033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.
    Li D; Jiao L; Li Y; Doll MA; Hein DW; Bondy ML; Evans DB; Wolff RA; Lenzi R; Pisters PW; Abbruzzese JL; Hassan MM
    Carcinogenesis; 2006 Jan; 27(1):103-11. PubMed ID: 15987714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain.
    Kogevinas M; Fernandez F; Garcia-Closas M; Tardon A; Garcia-Closas R; Serra C; Carrato A; Castano-Vinyals G; Yeager M; Chanock SJ; Lloreta J; Rothman N; Real FX; Dosemeci M; Malats N; Silverman D
    Eur J Cancer; 2006 Jul; 42(10):1448-54. PubMed ID: 16740387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes.
    Leggett CS; Doll MA; States JC; Hein DW
    Arch Toxicol; 2021 Jan; 95(1):311-319. PubMed ID: 33136180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.
    Godschalk RW; Dallinga JW; Wikman H; Risch A; Kleinjans JC; Bartsch H; Van Schooten FJ
    Pharmacogenetics; 2001 Jul; 11(5):389-98. PubMed ID: 11470992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
    Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ
    Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
    Gu J; Liang D; Wang Y; Lu C; Wu X
    Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
    Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
    Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytes.
    Habil MR; Doll MA; Hein DW
    Pharmacogenet Genomics; 2020 Apr; 30(3):61-65. PubMed ID: 31895247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
    Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA
    Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M; Michaud D; De Vivo I
    BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
    Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
    Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.